Lindbrook Capital’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $6.01K | Buy |
117
+7
| +6% | +$360 | ﹤0.01% | 1880 |
|
2024
Q4 | $6.09K | Hold |
110
| – | – | ﹤0.01% | 1897 |
|
2024
Q3 | $3.62K | Sell |
110
-9
| -8% | -$296 | ﹤0.01% | 2141 |
|
2024
Q2 | $3.23K | Buy |
119
+25
| +27% | +$679 | ﹤0.01% | 2188 |
|
2024
Q1 | $3.42K | Hold |
94
| – | – | ﹤0.01% | 2057 |
|
2023
Q4 | $1.9K | Hold |
94
| – | – | ﹤0.01% | 2279 |
|
2023
Q3 | $1.67K | Hold |
94
| – | – | ﹤0.01% | 2182 |
|
2023
Q2 | $1.7K | Buy |
+94
| New | +$1.7K | ﹤0.01% | 2212 |
|
2022
Q4 | – | Sell |
-106
| Closed | -$2K | – | 3027 |
|
2022
Q3 | $2K | Sell |
106
-11
| -9% | -$208 | ﹤0.01% | 2149 |
|
2022
Q2 | $2K | Buy |
+117
| New | +$2K | ﹤0.01% | 2056 |
|